免疫检查点抑制剂相关急性肾损伤中的细胞因子与免疫细胞表型
一项前瞻性研究纳入24例接受免疫检查点抑制剂(ICI)治疗期间发生急性肾损伤(AKI)的患者,其中ICI相关AKI(AKI-ICI)14例、其他原因AKI(AKI-other)10例。结果发现AKI-ICI患者肾组织CD4记忆T细胞、辅助性T细胞和树突状细胞增多,尿IL-2、IL-10和TNF-α升高(P均<0.05)。尿TNF-α区分AKI病因的能力较强(AUC=0.814,95%CI 0.623-1.00)。作者认为特定T细胞反应及其细胞因子可能提示AKI-ICI,尿TNF-α是有前景的生物标志物,TNF-α通路可能作为治疗干预的潜在靶点。
要点
- AKI-ICI患者肾组织CD4记忆T细胞、辅助性T细胞和树突状细胞较AKI-other患者增多。
- AKI-ICI患者尿IL-2、IL-10和TNF-α较AKI-other患者升高(P均<0.05)。
- 尿TNF-α区分AKI-ICI与AKI-other的AUC=0.814(95%CI 0.623-1.00)。
核心结论
- 特定T细胞反应及其细胞因子可能提示ICI相关AKI,并可能有助于区分AKI-ICI与AKI-other。
- 尿TNF-α是AKI-ICI有前景的生物标志物,AKI-ICI最常由急性间质性肾炎(AIN)引起,TNF-α通路可能作为治疗干预的潜在靶点。
研究设计与样本
- 前瞻性研究,纳入24例在ICI治疗期间发生AKI的参与者,判定为AKI-ICI 14例或AKI-other 10例。
- 比较两组肾脏炎症与损伤标志物(中性粒细胞明胶酶相关脂质运载蛋白、肾损伤分子-1)以及血浆和尿T细胞相关细胞因子(TNF-α、干扰素-γ、IL-2、IL-4、IL-6、IL-8、IL-9、IL-10)水平。
- 使用质谱流式细胞术系统比较两组全身循环和肾组织中的T细胞反应。
主要发现
- AKI-ICI患者较AKI-other患者肾组织中CD4记忆T细胞、辅助性T细胞和树突状细胞增多,尿细胞因子IL-2、IL-10和TNF-α升高(P均<0.05)。
- TNF-α对AKI病因的区分能力较强(曲线下面积=0.814,95%置信区间:0.623-1.00)。
- 具有记忆表型的CD4+ T细胞构成优势亚群。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Immune checkpoint inhibitors (ICIs) induce impressive antitumor responses but may lead to acute kidney injury (AKI) associated with ICI therapy (AKI-ICI). Biomarkers distinguishing AKI-ICI from AKI because of other causes (AKI-other) are currently lacking. Because ICIs block immunoregulatory pathways, we hypothesized that biomarkers related to immune cell dysregulation, including tumor necrosis factor alpha (TNF-α) and other markers of B and T cell activation in the systemic circulation and kidney tissue, may aid with the diagnosis of AKI-ICI. METHODS: This is a prospective study consisting of 24 participants who presented with AKI during ICI therapy, adjudicated to either have AKI-ICI (n = 14) or AKI-other (n = 10). We compared markers of kidney inflammation and injury (neutrophil gelatinase-associated lipocalin, kidney injury molecule-1) as well as plasma and urine levels of T cell-associated cytokines (TNF-α, interferon-γ, interleukin (IL)-2, IL-4, IL-6, IL-8, IL-9, and IL-10) between groups. We also compared T-cell responses in the systemic circulation and in kidney tissue across groups, using mass cytometry systems. RESULTS: We observed increase in several specific immune cells, including CD4 memory, T helper cells, and dendritic cells in the kidney tissue, as well as in the urine cytokines IL-2, IL-10, and TNF-α, in patients who developed AKI-ICI compared to patients with AKI-other (P < 0.05 for all). The discriminatory ability of TNF-α on AKI cause was strong (area under the curve = 0.814, 95% confidence interval: 0.623-1.00. The CD4+ T cells with memory phenotype formed the dominant subset. CONCLUSION: These results suggest that specific T-cell responses and their respective cytokines may be indicative of AKI associated with ICI therapy and may help to differentiate AKI-ICI from AKI-other. Urine TNF-α is a promising biomarker for AKI-ICI, which is most often caused by acute interstitial nephritis (AIN), and TNF-α pathway may serve as a potential target for therapeutic intervention.
引用
- Farooqui N, Zaidi M, Vaughan L, et al. Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors. Kidney Int Rep. 2022. PMID: 36938084. doi:10.1016/j.ekir.2022.11.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。